pharma industry

Pharma's U.S. reputation is bad—and Trump may be to blame: survey
Pharma's U.S. reputation is bad—and Trump may be to blame: survey
Fierce Pharma
Donald Trump
pharma industry
reputation
Flag link:
Buried in Trump’s executive order on drug pricing is a windfall clause for pharma
Buried in Trump’s executive order on drug pricing is a windfall clause for pharma
Stat
Donald Trump
drug pricing
pharma industry
Flag link:
Drugmakers must take the lead on opioid epidemic comms, say experts
Drugmakers must take the lead on opioid epidemic comms, say experts
Medical Marketing and Media
opioids
opioid crisis
pharma industry
Flag link:
Blurred Lines: The Convergence of Med Device and Pharma in 2017
Blurred Lines: The Convergence of Med Device and Pharma in 2017
Medical Device and Diagnostic Industry
devices
pharma industry
innovation
Flag link:
Pharma’s Identity Crisis: Four strategies for creating value in life sciences
Pharma’s Identity Crisis: Four strategies for creating value in life sciences
Pharmafile
pharma industry
R&D
M&A
competition
Flag link:
Pharma and biotech rebound in annual trust study, but there's still room for improvement
Pharma and biotech rebound in annual trust study, but there's still room for improvement
Fierce Pharma
trust
pharma industry
Flag link:
Pharma's Not So Stingy With R&D After All
Pharma's Not So Stingy With R&D After All
Forbes
R&D
pharma industry
Flag link:
Drug companies risk Trump's wrath as they march for science
Drug companies risk Trump's wrath as they march for science
CNBC
pharma industry
Donald Trump
science
Flag link:
Pharma's rep with patient groups was on the rise, but not anymore
Pharma's rep with patient groups was on the rise, but not anymore
Fierce Pharma
reputation
patients
pharma industry
Flag link:
Trump’s pick for FDA chief faces questions over ties to drug industry
Trump’s pick for FDA chief faces questions over ties to drug industry
Mass Device
Donald Trump
FDA
pharma industry
Scott Gottlieb
Flag link:
Pharma goes to Washington, Trump talks pricing
Pharma goes to Washington, Trump talks pricing
BioPharma Dive
pharma industry
drug pricing
Donald Trump
Eli Lilly
Amgen
Merck
Novartis
Celgene
JNJ
Flag link:
Q4 was a mixed bag for pharma. Will 2017 be the same?
Q4 was a mixed bag for pharma. Will 2017 be the same?
BioPharma Dive
pharma industry
Donald Trump
drug pricing
IPOs
Flag link:
Harris Poll: Only Nine Percent Of U.S. Consumers Believe Pharma And Biotechnology Put Patients Over Profits
Harris Poll: Only Nine Percent Of U.S. Consumers Believe Pharma And Biotechnology Put Patients Over Profits
TheStreet.com
patients
pharma industry
insurers
Flag link:
Can pharma give doctors what they want?
Can pharma give doctors what they want?
Medical Marketing and Media
physicians
pharma industry
EHRs
Flag link:
What Trump's Win Might Mean for Pharma
What Trump's Win Might Mean for Pharma
ZS Associates Active Ingredient
Donald Trump
pharma industry
Flag link:
Trump Presidency Could Offer New Challenges for Shaky Drug Sector
Trump Presidency Could Offer New Challenges for Shaky Drug Sector
TheStreet.com
Donald Trump
pharma industry
drug pricing
Flag link:
Pharma execs assess landscape under President Trump
Pharma execs assess landscape under President Trump
Drug Delivery Business
Donald Trump
pharma industry
drug pricing
Regeneron
Allergan
Flag link:
The drug industry’s stake in Trumpcare is bigger than you think
The drug industry’s stake in Trumpcare is bigger than you think
Stat
healthcare reform
Affordable Care Act
Trumpcare
pharma industry
Flag link:
Election verdict: Pharma needs a new prescription
Election verdict: Pharma needs a new prescription
Stat
2016 Presidential election
pharma industry
Donald Trump
Prop 61
Flag link:
Americans are increasingly critical of drug industry, a new poll finds
Americans are increasingly critical of drug industry, a new poll finds
Medical Marketing and Media
pharma industry
reputation
Flag link: